Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Active, not recruiting · NCT05184569 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology | Frontotemporal Lobar Degeneration, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, brain disorder, central nervous system disorder, cognitive disorder, dementia, frontotemporal dementia, metabolic disease, nervous system disorder, neurodegenerative disease, proteostasis deficiencies, psychiatric disorder, semantic dementia | Active, not recruiting | Phase 1 | 2026-07-06 | NCT05184569 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alzheimer's Association | 36 |
| National Institute on Aging (NIA) | 571 |
| National Institutes of Health (NIH) | 667 |
| Peter Ljubenkov, MD | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Houston Methodist Hospital - Nantz National Alzheimer Center | Houston | United States | 1 |
| Mayo Clinic | Rochester | United States | 664 |
| Northwestern University | Chicago | United States | 727 |
| UCSF Memory and Aging Center | San Francisco | United States | 3 |
| University of Pennsylvania | Philadelphia | United States | 507 |